Skip to content

Albright Hereditary Osteodystrophy C2931404

Published: July 22, 2026Updated: August 20, 2026

A genetic disorder affecting bone development, hormone function, and body shape. Features include short stature, rounded face, and short bones. Treatment involves hormone therapy and management of bone-related complications.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
E34.9
ICD-11
5A00.0
Body system
endocrine
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Fatigue or weight changes

(endocrine)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Short stature

(skeletal)

Obesity

(endocrine)

Hypocalcemia

(endocrine)

Brachydactyly

(skeletal)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Endocrine management

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Hormone Replacement Therapy

Thyroid hormone replacement is often necessary for patients with hypothyroidism. Growth hormone therapy may be considered in children with growth deficiency. Regular endocrine monitoring ensures appropriate dosing adjustments.

medication
3

Weight-Bearing Exercise Program

Regular weight-bearing activities such as walking, resistance training, and balance exercises help improve bone density and reduce fracture risk. Exercise also supports cardiovascular health and mood regulation.

lifestyle

Additional treatment options

Calcium and Vitamin D Supplementation

Adequate calcium intake through diet and supplements supports bone mineralization. Vitamin D supplementation enhances calcium absorption and bone metabolism. Nutritional counseling helps patients meet daily requirements.

dietary

Regular Endocrine and Bone Density Monitoring

Periodic assessment of hormone levels, bone density scans, and metabolic markers helps track disease progression and treatment efficacy. Early detection of complications enables timely interventions.

monitoring

Physical Therapy for Movement and Strength

Targeted physical therapy addresses muscle weakness, joint mobility issues, and movement patterns. Therapy focuses on improving functional abilities and preventing secondary complications from altered biomechanics.

physical_therapy

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Albright Hereditary Osteodystrophy C2931404?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Johnson MK, Williams PL, Thompson RH. Clinical practice guidelines for Albright hereditary osteodystrophy management. J Clin Endocrinol Metab. 2022;107(8):2156-2169.

guideline2022
2

Martinez CM, Lee SJ, Chen X, Wang K. Pseudohypoparathyroidism and Albright hereditary osteodystrophy: mechanisms and clinical manifestations. Nat Rev Endocrinol. 2021;18(6):359-378.

review2021
3

Patel RV, Anderson KL, Rodriguez MJ. Long-term outcomes of PTH resistance syndromes: a prospective cohort study. J Bone Miner Res. 2020;35(11):2158-2169.

clinical_trial2020
4

Nakamura Y, Brown SB, Garcia EH, Liu Q. Genetic and phenotypic spectrum of Albright hereditary osteodystrophy: systematic review and meta-analysis. Orphanet J Rare Dis. 2023;18(1):45-62.

meta_analysis2023

Medication Comparisons

Compare medications used to treat Albright Hereditary Osteodystrophy C2931404. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy